Cysteine Conjugate β-Lyase-dependent Biotransformation of the Cysteine S-Conjugates of the Sevoflurane Degradation Product Compound A in Human, Nonhuman Primate, and Rat Kidney Cytosol and Mitochondria
- 1 December 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 85 (6), 1454-1461
- https://doi.org/10.1097/00000542-199612000-00028
Abstract
2-(Fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A) is a fluorinated alkene formed by the degradation of sevoflurane in the anesthesia circuit. Compound A is toxic to the kidneys in rats and undergoes glutathione-dependent metabolism in vivo. Several nephrotoxic halogenated alkenes also undergo cysteine conjugate beta-lyase-dependent biotransformation. These experiments were designed to test the hypothesis that cysteine S-conjugates of compound A undergo beta-lyase-dependent biotransformation. S-[2-(Fluoromethoxy)-1,1,3,3,3-pentafluoropropyl]-L-cysteine 4, S-[2-(fluoromethoxy)-1,3,3,3-tetrafluoro-1-propenyl]-L-cysteine 5, and S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine 11 were incubated with rat, human, and nonhuman primate (cynomolgus, rhesus, and marmoset) kidney cytosol and mitochondria. beta-Lyase activity was determined by measuring pyruvate formation. Compound A-derived conjugates 4 and 5 as well as conjugate 11, a positive control, were substrates for cytosolic and mitochondrial beta-lyase from human, nonhuman primate, and rat kidney. For all substrates, beta-lyase activity was highest in the rat and lowest in the human and was higher in cytosol than in mitochondria. Conjugate 11 was a much better substrate than conjugates 4 or 5. The biotransformation of conjugates 4, 5, and 11 was inhibited by the beta-lyase inhibitor (aminooxy)acetic acid and was stimulated by the amino group acceptor 2-keto-4-methylthiolbutyric acid, indicating a role for beta-lyase. These data confirm the presence of beta-lyase activity in human and rat kidney and show that activity is also present in kidney tissue from nonhuman primates. The data also show that compound A-derived conjugates 4 and 5 undergo beta-lyase-catalyzed biotransformation. beta-Lyase activity in rat and nonhuman primate kidney tissue was 8 to 30 times and one- to three times, respectively, higher than in human kidney tissue.Keywords
This publication has 35 references indexed in Scilit:
- Nephrotoxicity in Rats Undergoing a One-Hour Exposure to Compound AAnesthesia & Analgesia, 1995
- Nephrotoxicity of Sevoflurane Compound A [Fluoromethyl-2,2-Difluoro-1-(Trifluoromethyl)Vinyl Ether] in Rats: Evidence for Glutathione and Cysteine Conjugate Formation and the Role of Renal Cysteine Conjugate β-LyaseBiochemical and Biophysical Research Communications, 1995
- Plasma Inorganic Fluoride and Intracircuit Degradation Product Concentrations in Long-Duration, Low-Flow Sevoflurane AnesthesiaAnesthesia & Analgesia, 1994
- Toxicity of Compound A in RatsAnesthesiology, 1994
- Toxicity of Compound A in RatsAnesthesiology, 1994
- Formation and Fate of Nephrotoxic and Cytotoxic Glutathione S-Conjugates: Cysteine Conjugate β-Lyase PathwayPublished by Elsevier ,1994
- Reaction of Sevoflurane and Its Degradation Products with Soda LimeAnesthesiology, 1992
- Quantification of the Degradation Products of Sevoflurane in Two CO2 Absorbants during Low-flow Anesthesia in Surgical PatientsAnesthesiology, 1992
- Bioactivation mechanism of the cytotoxic and nephrotoxic S-conjugate S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine.Proceedings of the National Academy of Sciences, 1987
- Volatile Metabolites and Decomposition Products of Halothane In ManAnesthesiology, 1979